Related Experiment Video
Updated: Jun 26, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Antioxidant therapies for obstructive sleep apnea: A systematic review and meta-analysis
Tarun Krishna Boppana1, Saurabh Mittal2, Karan Madan1
1Department of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India, 110029.
Purpose:
Obstructive sleep apnea (OSA) is a common clinical problem that is associated with adverse cardiovascular outcomes attributed to the oxidative stress due to sympathetic overstimulation. Treatment approaches targeting oxidative stress have been tried by multiple investigators. This systematic review and meta-analysis evaluated the efficacy and safety of such approaches.
Methods:
Pubmed and Embase databases were searched for human studies evaluating the utility of antioxidant therapies in patients with OSA.
Results:
A total of six studies (five randomized trials and one case-control study) were included, including 160 patients with OSA using N-acetyl cysteine, vitamin C, carbocysteine, superoxide dismutase, vitamin E, allopurinol, and their combinations. There was a significant improvement in flow-mediated dilatation (FMD) following antioxidants, with the pooled effect being 2.16 % (95% CI 1.65-2.67) using the random-effects model (I2 = 0% and p<0.001). It was also associated with a significant reduction in malondialdehyde levels and an increase in reduced glutathione (GSH) levels. There was also a significant improvement in the Epworth sleepiness scale, oxygen desaturation index, and minimum oxygen saturation during sleep without any significant adverse effects.
Conclusion:
Antioxidant therapy in patients with OSA is associated with improved endothelial function, reduced oxidative stress, and improved sleep parameters. These results call for future multicentre studies with longer follow-ups to assess the utility of antioxidant therapy in patients with OSA.
Insights
Antioxidant therapy significantly improves endothelial function and sleep quality in obstructive sleep apnea (OSA) patients. This approach reduces oxidative stress without adverse effects, suggesting potential for future clinical use.
Area of Science:
- Cardiovascular Medicine
- Sleep Medicine
- Pharmacology
Background:
- Obstructive sleep apnea (OSA) is linked to cardiovascular issues driven by oxidative stress and sympathetic overactivity.
- Targeting oxidative stress is a potential therapeutic strategy for OSA management.
Purpose of the Study:
- To systematically review and meta-analyze the efficacy and safety of antioxidant therapies in patients with OSA.
Main Methods:
- Searched PubMed and Embase for human studies on antioxidant therapies in OSA patients.
- Included six studies (five RCTs, one case-control) with 160 OSA patients.
Main Results:
- Antioxidants significantly improved flow-mediated dilatation (FMD) by 2.16% (95% CI 1.65-2.67).
- Reduced malondialdehyde and increased glutathione levels, indicating decreased oxidative stress.
- Improved Epworth sleepiness scale, oxygen desaturation index, and minimum oxygen saturation without adverse effects.
Conclusions:
- Antioxidant therapy enhances endothelial function, reduces oxidative stress, and improves sleep parameters in OSA.
- Further multicenter studies with longer follow-up are warranted to confirm the utility of antioxidant therapy for OSA.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Management of Insomnia
COPD: Management Using Bronchodilators and Corticosteroids
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

